|
楼主 |
发表于 2008-12-16 14:37:43
|
显示全部楼层
参考文献:( A/ @& C$ u6 w5 I: c( Q
E C Keystone. Advances in targeted therapy: safety of biological agents. Ann Rheum Dis.,2003.(Supplfl):ii34一ii36 , W* I- l7 c4 `8 O
Peter K. Gregersen, Richard Bucala. Macrophage Migretion Inhibitory Factor, MIF Allels, and the Genetics of Inflammatory Disorders: Incorporating Disease Outcome Into the Definition of Phenotype. Arthritis&Rheumatism, 2003.48(5):1171一1176
0 a' O+ W w y2 a' P' N( L Cora Vizcarra. New Perspectives and Emerging Therpies for Immune-mediated inflammatory Disorders. Journal of InfusionNursing, 2003.26(5):319一325
3 `7 d1 {% O# t5 l0 g! Y- Y8 Q4 ? Hiroaki Ito. IL-6 and Corhn' s disease. Current Drug Targets-inflammation&Allergy, 2003.2:125一130
: Q1 A7 u& f9 X9 k! t Carol Dukes Hamilton. Tuberculosis in the Cytokine Era: Whgt Rheumatologists Need to Know. Arthritis&Rheumatism,2003.48(8):2085一2091 o4 c5 T w+ l6 {/ c7 }
Gary S. Firestein. Evolving concepts of rheumatoid arthritis. Nature, 2003.423(15):356一361
$ \* i W, Z9 v! L P: N Peter K. K. Wong, Ian K. Campbell, Paul Jean et al. The Role of the Interleukin-6 Family of Cytokines in Inflammatory Arthritis and Bone Turnover. Arthritis& Rheumatism, 2003.48(5):1177一1189
$ }( S4 J9 _5 E- Z# C0 D) c F Y Liew, X-Q Wei, I B Mclnnes. Role of interleukin 18 in rheumatoid arthritis. Ann Rheum Dis.,2003.62(SupplIj):ii48一550
7 A2 Y, X V4 f$ H" x" k I B Mclnnes, J A Gracie, M Harnett, F Y Liew. New strategies to control inflammatory synovitis: interleukin 15 and beyond. Ann Rheum Dis.,2003.62(Supp1II):ii51一ii54 - K) b+ ]4 L% S% P& s! k
Krishna M. sundar, Marc V. Gosselin, et al. Emerging Concepts in Pathobiology, Radiology, and Clinical Evolution of disease. Pulmonary Langerhans Cell Histiocytosis. Chest, 2003.123:1673一1683
6 |8 K) { i: H9 D+ Y; x PD Robbins, CH Evans, Y Chernajovsky. Gene therapy for arthristis. Gene Therapy, 2003.10:902一911 . O, W( Z4 z" h* f) X3 `: I& X6 |
Tohru Abe, Tsutomu Takeuchi. Rheumatoid Arthritis and Tumor Necrosis Factor a. Autommunity, 2001.34:291一303 1 r0 d* a, a. C. X7 o3 l6 R. {5 ]
Ernest H. S. Choy, Grbriel S. Panayi: Cytokine pathways and joint inflammatory in rheumatoid arthritis. Mechanisms of Disease. N Engl J Med, 2001.344(12):22
b( k- ?' b0 ^( n! ^# f& g Leonardo Punzi, Lorenzo Calo, Mario Plebani. Clinical Significance of Cytokine Determination in Synovial Fluid. Critical Reviews in Clinical Laboratory Sciences, 2002. 39(1) :63一88 ! R) a& S4 ^/ g" Z" K) d
Joseph C. Shanahan, E. William St. Clair. Tumor Necrosis Factor-a Blockade: A Novel Therapy for Rheumatic Disease. Clinical Immunology, 2002 ,103 (3) :231一242, Part 1 of 2 parts
2 l' F+ A) g9 F: l. N3 t Naoyuki Tsuchiya, Jun Ohashi, Katsushi Tokunaga. Variations in immune response genes and their associations with multifactorial immune disorders. Immunological Reviews, 2002.190:169一181 ! ]2 j7 X% S+ ]8 Y
成冰燕,王占元.细胞因子与类风湿关节炎治疗的研究进展.药学实践杂志,2000.18(3):143一144 1 G1 ^% `, U' i7 m% f
王玉树.类风湿关节炎治疗靶点研究进展.国外医学预防、诊断、治疗用生物制品分册,2002.25(5):222一226
" Q9 K$ ^* x H0 e, A F Y Liew, I B McInnes. Role of interleukin 15 and interleukin 18 in inflammatory response. Ann Rheum Dis.,2002.61 (suppl 11) : ii 100一ii102
* a2 ~, ?- q, T' E; p7 ] 张信来,刘陶迪 类风湿关节炎与白细胞介素-1.生理科学进展,1999.30(3):252一254 9 ? b) [) }' y& m
费克香,雷元卫.类风湿关节炎免疫功能异常的研究进展.国外医学免疫学分册,1999.22(6):323一326
6 s4 ^# |. N t Thomas Pap,Ulf Muller-Ladner. Renate Gay&Steffen Gay: Gene Therapy Promising For Rheumatoid Arthritis. Arthritis Res.,1999. 1(1):5一9
6 a( G8 Z( a$ M Jean-Michel Dayer, Barry Bresnihan. Targeting Interleukin1 in the Treatment of Rheumatoid Arthritis. Arthritis & Rheumatism. 2002,46(3)574一578 / c# R2 L" }; F9 u
黄启阳,于孟学,姜玉娟,董怡.应用细胞因子及其拮抗剂治疗类风湿关节炎的进展.北京医学,1996.18(2):102一105
@# W) W7 ]9 W Wim B van den Berg. Anti-cytokine therapy in chronic destructive arthritis. Arthritis Res.,2001.3:18一26 $ B0 O) y# w* J% r" W9 }
Katsuhiko Ishihara, Toshio Hirano. IL-6 in autoimmune disease and chronic inflammatory prolixferative disease. Cytokine & Crowth Factor Reviews, 2002.13:357一368
5 U. N7 q7 R1 L) c( f; E7 }% G, C K Yoichiro Iwakura. Roles of IL-1 in the development of rheumatoid arthritis: consideration from mouse models. Cytokine & Crowth Factor Reviews, 2002.13:341一355 |
|